Therapies for Renal Ciliopathies

Project Information

TheRaCil

Grant agreement ID: 101080717

DOI

10.3030/101080717

EC signature date 4 May 2023

Start date 1 July 2023

End date 30 June 2027

Funded under

• Health

Total cost

€ 7 425 446,80

EU contribution

€ 7 425 446,80

Coordinated by

IMAGINE INSTITUT DES MALADIES GENETIQUES NECKER ENFANTS MALADES FONDATION
France

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Data Management Plan (2)

Data Management Plan

Document describing the data management plan that will be produced and provided

Data Management Plan 2

We will revise the data management plan at month 18

Other (1)

PELSI Advisory Board

stakeholder's opinion reports and guidelines with clinical, EMA reports for ODD, PA and Biomarkers qualification.

Websites, patent fillings, videos etc. (1)

Project website

Public website dedicated to the TheRaCil project

Publications

Peer reviewed articles (5)

Metabolic reprogramming in polycystic kidney disease and other renal ciliopathies

Author(s): Sara Clerici; Alessandra Boletta
Published in: EMBO Molecular Medicine, 2025, ISSN 1757-4684
Publisher: Nature Publishing Group UK
DOI: 10.1038/S44321-025-00239-X

Prostaglandin Analogs and Eupatilin as Treatments for Nephronophthisis

Author(s): Alice Tata, Guillaume Rocha, Marguerite Hureaux, Alice S. Serafin, Esther Porée, Lucie Menguy, Nicolas Goudin, Nicolas Cagnard, Lilian Gréau, Marc Fila, Luis Briseño-Roa, Jean-Philippe Annereau, Sophie Saunier, Alexandre Benmerah
Published in: Kidney International Reports, 2025, ISSN 2468-0249
Publisher: Elsevier BV
DOI: 10.1016/J.EKIR.2025.04.060

Polycystic Kidney Disease in Children: The Current Status and the Next Horizon

Author(s): Melissa A. Cadnapaphornchai, Katherine M. Dell, Charlotte Gimpel, Lisa M. Guay-Woodford, Ashima Gulati, Erum A. Hartung, Max C. Liebau, Andrew J. Mallett, Matko Marlais, Djalila Mekahli, Alixandra Piccirilli, Tomas Seeman, Kristin Tindal, Paul J.D. Winyard
Published in: American Journal of Kidney Diseases, 2025, ISSN 0272-6386
Publisher: Elsevier BV
DOI: 10.1053/J.AJKD.2025.01.022

Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease

Author(s): Kathrin Burgmaier, Bénédicte Buffin-Meyer, Julie Klein, Brian Becknell, Daryl McLeod, Jan Boeckhaus, Oliver Gross, Claudia Dafinger, Justyna Siwy, Stéphane Decramer, Franz Schaefer, Max C Liebau, Joost P Schanstra
Published in: Clinical Kidney Journal, Issue 18, 2025, ISSN 2048-8505
Publisher: Oxford University Press (OUP)
DOI: 10.1093/CKJ/SFAF093

Pathogenic PHIP Variants are Variably Associated With CAKUT

Author(s): Jonathan de Fallois; Tobias Sieckmann; Ria Schönauer; Friederike Petzold; Johannes Münch; Melissa Pauly; Georgia Vasileiou; Christin Findeisen; Antje Kampmeier; Alma Kuechler; André Reis; Eva Decker; Carsten Bergmann; Konrad Platzer; Velibor Tasic; Karin Michaela Kirschner; Shirlee Shril; Friedhelm Hildebrandt; Wendy K. Chung; Jan Halbritter
Published in: Kidney International Reports, 2024, ISSN 2468-0249
Publisher: Elsevier BV
DOI: 10.1016/J.EKIR.2024.05.024

Conference proceedings (1)

Comparing representations of long clinical texts for the task of patient note-identification

Author(s): Safa Alsaidi, Marc Vincent, Olivia Boyer, Nicolas Garcelon, Miguel Couceiro, Adrien Coulet
Published in: CL4Health@NAACL 2025, 2025
Publisher: HAL